NDA - Europe's leading Regulatory Service provider
If anyone can make sure that the best possible medicines reach the patients without unnecessary delay – it’s NDA.
In all we do at NDA, our aim is to shorten the expensive and time consuming process of getting effective and reliable medicines to the market.
NDA can achieve this by providing our clients with an extensive portfolio of services that are optimised to meet the standards of the regulatory authorities.
NDA's clients benefit from our input into development plans and regulatory assistance during the complete life span of their products.
In short, NDA strive to bridge the communication gap between the regulated and the regulators – to the ultimate benefit of patients
Let’s not keep them waiting.
Let’s bring medicines to the world.
28-30 July 2009, Regulatory Affairs Summer School, University of CambridgeDr. Brian Edwards, Director Pharmacovigilance & Drug Safety will present:
Optimising risk management planning
Dr. Janice Kirby Smith, Associate Director will present:
Ensuring complete compilation of CMC data
For registration and additional information please click here. 22 - 24 September 09, User Bridge.09 - Lorenz User ConferenceVenue: Sofitel Victoria in Warsaw, Poland
Ms Inge Neubauer, NDA and Ms Elke Klein, NDA, will present:
Optimizing Global Submission Management - from first draft to final submission
For more information please click here. Electronic Publishing Services at the NDA GroupLet us help your organisation benefit from eCTD.
more information
The NDA Group is an independent consulting organization focused on the strategic and operational aspects of regulatory affairs. NDA provides assistance to both the Pharmaceutical Industry as well as Regulatory Agencies. The ultimate objective of NDA is to help to develop better medicines that reach the patient without unnecessary delay. NDA achieves this objective by critically reviewing client project development plans with the aim that they are optimized to meet the needs of regulatory authorities and then to help to implement those strategies. NDA strives to bridge the communication gap between "the regulators" and "the regulated" to the benefit of patients.
The NDA Group provides services within several different areas such as regulatory affairs, pharmacovigilance and patient safety, readability testing, quality assurance. NDA works with traditional pharmaceuticals, biopharma, medical devices and production processes within the pharmaceutical industry.
The NDA Group also provides expert and strategical advice on development and regulatory strategies and assists the pharmaceutical industry with qualified training.
|
